2,890 hedge funds and large institutions have $106B invested in Pfizer in 2024 Q3 according to their latest regulatory filings, with 190 funds opening new positions, 1,236 increasing their positions, 1,189 reducing their positions, and 126 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

1% more capital invested

Capital invested by funds: $105B → $106B (+$1.23B)

1.2% less ownership

Funds ownership: 65.92%64.72% (-1.2%)

38% less call options, than puts

Call options by funds: $2.51B | Put options by funds: $4.05B

Holders
2,890
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
40
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.51B
Puts
$4.05B
Net Calls
Net Calls Change

Top Buyers

1 +$421M
2 +$372M
3 +$343M
4
BlackRock
BlackRock
New York
+$336M
5
Deutsche Bank
Deutsche Bank
Germany
+$284M

Top Sellers

1 -$997M
2 -$357M
3 -$263M
4
Franklin Resources
Franklin Resources
California
-$261M
5
DCP
D1 Capital Partners
New York
-$213M
Name Holding Trade Value Shares
Change
Change in
Stake
1951
$499K
1952
$498K
1953
$497K
1954
$496K
1955
$496K
1956
$496K
1957
$495K
1958
$495K
1959
$495K
1960
$494K
1961
$493K
1962
$493K
1963
$493K
1964
$493K
1965
$492K
1966
$489K
1967
$488K
1968
$487K
1969
$487K
1970
$486K
1971
$486K
1972
$486K
1973
$485K
1974
$485K
1975
$484K